Fabry disease is an inherited disorder where patients do not produce enough of the enzyme alpha-galactosidase A, which prevents fat-like sphingolipids from collecting in blood vessels and tissues. This can affect the heart, kidneys, brain, nervous system, and skin. There are two main types: classic Fabry disease begins in childhood/teenage years and gets progressively worse over time, while late-onset/atypical type has symptoms starting in the 30s or older. Symptoms include pain, tingling or burning in hands/feet, heart or kidney problems, skin lesions, and others. Treatment involves enzyme replacement therapy via IV every two weeks or oral medication to repair faulty enzymes. Complications can